Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic alterations of 9p24 in lymphomas and their impact for cancer (immuno-)therapy.

Virchows Archiv : an international journal of pathology - 1 Apr 2019

Menter Thomas, Tzankov Alexandar

Abstract excerpt

Chromosome 9 harbors several relevant oncogenes related to hematolymphoid malignancies and one specific region, 9p24, has come into the focus of attention in the last years as it contains recurrently mutant genes of therapeutic interest. The most prominent genes of this locus are programmed death ligands 1 and 2 (PDL1/PDL2), with the amplification of PDL1 being a hallmark of both classical Hodgkin and primary...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to B7-H1 Antigen
Share to Chromosomes, Human, Pair 9
Share to Immunotherapy

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Janus Kinase 2

Share to Lymphoma

Share to Membrane Proteins

Share to Mutation

Share to Tumor Suppressor Proteins

Source

Identifiers

PMID: 30132131
DOI: 10.1007/s00428-018-2438-6

Genes

JAK2
PCM1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic alterations of 9p24 in lymphomas and their impact for cancer (immuno-)therapy.PMID 30132131Read ↗

Genomic alterations of the JAK2 and PDL loci occur in a broad spectrum of lymphoid malignancies.Semantic proximity Read ↗

[Molecular abnormalities in lymphomas].Semantic proximity Read ↗

Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphomaSemantic proximity Read ↗

Genetic lesions and targeted therapy in Hodgkin lymphomaSemantic proximity Read ↗

Recent Advances in the Genetic of MALT LymphomasSemantic proximity Read ↗

PD-L1 overexpression correlates with JAK2-V617F mutational burden and is associated with 9p uniparental disomy in myeloproliferative neoplasms.Semantic proximity Read ↗

Structural genomic alterations in primary mediastinal large B-cell lymphoma.Semantic proximity Read ↗

Genomic rearrangements involving programmed death ligands are recurrent in primary mediastinal large B-cell lymphoma.Semantic proximity Read ↗

<scp><i>MYD88</i></scp> somatic mutations in <scp>MALT</scp> lymphomasSemantic proximity Read ↗

<i>PD-L1</i> and <i>PD-L2</i> Genetic Alterations Define Classical Hodgkin Lymphoma and Predict OutcomeSemantic proximity Read ↗

Advances in the understanding of MYC‐induced lymphomagenesisSemantic proximity Read ↗

9p24.1 alterations and programmed cell death 1 ligand 1 expression in early stage unfavourable classical Hodgkin lymphoma: an analysis from the German Hodgkin Study Group NIVAHL trial.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.